Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

L-Lysine-N-acetyl-L-cysteinate

EU orphan designation number: EU/3/01/026   
Active ingredient: L-Lysine-N-acetyl-L-cysteinate
Indication: Treatment of cystic fibrosis
Sponsor: LABORATOIRES SMB SA
26-28 rue de la Pastorale / 26-28 Herdersliedstraat, 1080 Brussel/Bruxelles, Belgique/BelgiŽ

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/02/2001 Centralised Orphan - Designation EMEA/OD/032/00 (2001)363 of 14/02/2001
08/02/2011 Centralised Orphan - Transfer of orphan designation EMEA/OD/032/00/T/01 (2011)779 of 04/02/2011